初靈信息(300250.SZ):中標中國電信接入型M-OTN設備集中採購項目
格隆匯10月23日丨初靈信息(300250.SZ)公佈,中國電信陽光采購網發佈了《中國電信接入型M-OTN設備(2023年)集中採購項目》,公司為上述項目的中標候選人之一。近日,收到了《中標通知書》,中標金額1353萬元。
公司邊緣智能連接中標的接入型M-OTN設備全面支持光業務單元(OSU)技術,採用更小的時隙粒度(Mbps級),支持海量的彈性硬管道連接,提供可承諾的確定性低時延,完善的端到端OAM功能,滿足城域網專線承載場景的高品質需求,此次中標實現了公司在F5G Advanced領域和OTN精品專線市場的突破,提升了公司的競爭力,將對公司邊緣計算智能連接業務產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.